Cargando…

Interactions of different drug resistance mutations in HIV Reverse Transcriptase in defining patterns of drug resistance

Detalles Bibliográficos
Autor principal:	Wainberg, Mark A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236858/ http://dx.doi.org/10.1186/1742-4690-8-S2-O14

Ejemplares similares

The Need for Development of New HIV-1 Reverse Transcriptase and Integrase Inhibitors in the Aftermath of Antiviral Drug Resistance
por: Wainberg, Mark A.
Publicado: (2012)

Reverse transcriptases of retroviruses and retroelements: an evolutionary perspective
por: Arkhipova, Irina R
Publicado: (2009)

Aptamers that recognize drug-resistant HIV-1 reverse transcriptase
por: Li, Na, et al.
Publicado: (2008)

The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance
por: Acosta-Hoyos, Antonio J., et al.
Publicado: (2010)

Aptamers that recognize drug-resistant HIV-1 reverse transcriptase
por: Li, Na, et al.
Publicado: (2009)

The changing face of HIV resistance; HIV drug resistance north and south — what's next?
por: Schapiro, J
Publicado: (2010)

Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase
por: Siedner, Mark J., et al.
Publicado: (2020)

Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase
por: Singh, Kamalendra, et al.
Publicado: (2010)

Feasibility of testing and detection of HIV-1 drug resistance in proviral DNA
por: Booth, Clare L, et al.
Publicado: (2014)

Effects of the K65R and K65R/M184V reverse transcriptase mutations in subtype C HIV on enzyme function and drug resistance
por: Xu, Hong-Tao, et al.
Publicado: (2009)

HIV-1 CRF08_BC mutants resistant to reverse transcriptase inhibitors
por: Wu, Hao, et al.
Publicado: (2014)

Mutations in the C-terminal region of the HIV-1 reverse transcriptase and their correlation with drug resistance associated mutations and antiviral treatment
por: Michels, I, et al.
Publicado: (2010)

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana
por: Moyo, Sikhulile, et al.
Publicado: (2019)

Analysis of drug resistance to HIV-1 protease using fitness function in genetic algorithm
por: Harishchander, A, et al.
Publicado: (2012)

Revealing the Mutation Patterns of Drug-Resistant Reverse Transcriptase Variants of Human Immunodeficiency Virus through Proteochemometric Modeling
por: Qiu, Jingxuan, et al.
Publicado: (2021)

The global challenge of antimalarial drug resistance
por: Ringwald, Pascal, et al.
Publicado: (2012)

HIV reverse transcriptase: Structural interpretation of drug resistant genetic variants from India
por: Kandathil, Abraham Joseph, et al.
Publicado: (2009)

Sequence and structure based models of HIV-1 protease and reverse transcriptase drug resistance
por: Masso, Majid, et al.
Publicado: (2013)

Prevalence of Primary HIV Drug Resistance in Thailand Detected by Short Reverse Transcriptase Genotypic Resistance Assay
por: Kiertiburanakul, Sasisopin, et al.
Publicado: (2016)

The frequencies of naturally occurring protease inhibitor resistance mutations in HIV proviral sequences of drug naïve sex workers in Nairobi, Kenya and their correlation with host immune response driven positively selected mutations in HIV-1
por: Sampathkumar, Raghavan, et al.
Publicado: (2014)

Clinical impact of ultra deep versus Sanger sequencing detection of minority mutations on HIV-1 drug resistance genotype interpretation after virological failure
por: Mohamed, Sofiane, et al.
Publicado: (2014)

HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals
por: Bokharaei-Salim, Farah, et al.
Publicado: (2020)

Substitutions in the Reverse Transcriptase and Protease Genes of HIV-1 Subtype B in Untreated Individuals and Patients Treated With Antiretroviral Drugs
por: Turner, Dan, et al.
Publicado: (2005)

Long-term probability of detecting drug-resistant HIV in patients starting antiretroviral therapy within the first year of HIV infection
por: Lodi, S, et al.
Publicado: (2010)

Reverse transcriptase drug resistance mutations in HIV-1 subtype C infected patients on ART in Karonga District, Malawi
por: Bansode, Vijay B, et al.
Publicado: (2011)

Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors
por: Singh, Kamalendra, et al.
Publicado: (2014)

Reverse transcriptase and protease inhibitors mutational viral load in HIV infected pregnant women with transmitted drug resistance in Argentina
por: Cecchini, Diego, et al.
Publicado: (2021)

The Lysine 65 Residue in HIV-1 Reverse Transcriptase Function and in Nucleoside Analog Drug Resistance
por: Garforth, Scott J., et al.
Publicado: (2014)

Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations
por: Reuman, Elizabeth C., et al.
Publicado: (2010)

Drug resistance patterns in new and previously treated patients with tuberculosis presenting to a tertiary care center in southern India
por: Udaykumar, Anto J, et al.
Publicado: (2014)

Human immunodeficiency virus coinfection with drug-resistant Mycobacterium tuberculosis
por: Zaharia-Kézdi, Iringó Erzsébet, et al.
Publicado: (2013)

Cytotoxic T cell recognition of an HIV-1 reverse transcriptase variant peptide incorporating the K103N drug resistance mutation
por: Mahnke, Lisa, et al.
Publicado: (2006)

Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq
por: Dudley, Dawn M, et al.
Publicado: (2014)

Genetic and antiretroviral drug resistance mutations analysis of reverse transcriptase and protease gene from Pakistani people living with HIV-1
por: Siddiqui, Dilsha, et al.
Publicado: (2023)

The R263K mutation in HIV integrase that is selected by dolutegravir may actually prevent clinically relevant resistance to this compound
por: Wainberg, Mark, et al.
Publicado: (2014)

Development of Elvitegravir Resistance and Linkage of Integrase Inhibitor Mutations with Protease and Reverse Transcriptase Resistance Mutations
por: Winters, Mark A., et al.
Publicado: (2012)

Antiretroviral drug resistance and viral tropism in HIV-1 CRF06_cpx infected patients failing antiretroviral (ARV) therapy
por: Pauskar, Merit, et al.
Publicado: (2014)

The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of Multi-Drug-Resistant Mutations
por: Maldonado, José O., et al.
Publicado: (2018)

OA011-02. Defining the mechanisms of HIV entry and interactions with the female genital tract
por: Carias, AM, et al.
Publicado: (2009)

Elucidating molecular interactions of L-nucleotides with HIV-1 reverse transcriptase and mechanism of M184V-caused drug resistance
por: Hung, Magdeleine, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5k02ajln6v3am8cd129s5hjq03